Diamyd Medical AB Stock Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.03B 11.11B 1.41B |
---|---|---|---|---|---|
Net income 2018 | 25M 270M 34.21M | Net income 2019 | 77M 833M 105M | EV / Sales 2018 | - |
Net cash position 2018 | 253M 2.73B 346M | Net cash position 2019 | 83.08M 898M 114M | EV / Sales 2019 | - |
P/E ratio 2018 |
28.3
x | P/E ratio 2019 |
13.3
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 68.13% |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |